Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Co-existence of Parkinson's disease and progressive supranuclear palsy: case report and a review of the literature.

Abhinav K, Marsh L, Crain B, Reich SG, Biglan K.

Neurol Sci. 2011 Feb;32(1):159-63. doi: 10.1007/s10072-010-0386-2. Epub 2010 Aug 25. Review.

PMID:
20737180
2.

Co-occurrence of Parkinson's disease with progressive supranuclear palsy.

Judkins AR, Forman MS, Uryu K, Hinkle DA, Asbury AK, Lee VM, Trojanowski JQ.

Acta Neuropathol. 2002 May;103(5):526-30. Epub 2002 Jan 17.

PMID:
11935271
3.

Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.

Litvan I, Mangone CA, McKee A, Verny M, Parsa A, Jellinger K, D'Olhaberriague L, Chaudhuri KR, Pearce RK.

J Neurol Neurosurg Psychiatry. 1996 Jun;60(6):615-20.

4.

Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.

Jellinger KA.

Neurodegener Dis. 2008;5(6):339-46. doi: 10.1159/000121388. Epub 2008 Mar 18.

PMID:
18349518
5.

Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.

Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y.

Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10.

PMID:
19903734
6.

Coexistence of PSP and MSA: a case report and review of the literature.

Uchikado H, DelleDonne A, Uitti R, Dickson DW.

Acta Neuropathol. 2006 Feb;111(2):186-92. Epub 2006 Feb 3. Review.

PMID:
16456665
7.

Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.

Caparros-Lefebvre D, Sergeant N, Lees A, Camuzat A, Daniel S, Lannuzel A, Brice A, Tolosa E, Delacourte A, Duyckaerts C.

Brain. 2002 Apr;125(Pt 4):801-11.

PMID:
11912113
8.

Progressive supranuclear palsy and Parkinson's disease overlap: A clinicopathological case report.

Araki K, Sumikura H, Matsudaira T, Sugiura A, Takao M, Murayama S, Obi T.

Neuropathology. 2016 Apr;36(2):187-91. doi: 10.1111/neup.12259. Epub 2015 Sep 21.

PMID:
26388542
9.

Autonomic dysfunction in patients with progressive supranuclear palsy.

Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Reichmann H, Berg D, Ziemssen T.

Mov Disord. 2008 Oct 30;23(14):2083-9. doi: 10.1002/mds.22289.

PMID:
18792126
10.

Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.

Litvan I, Campbell G, Mangone CA, Verny M, McKee A, Chaudhuri KR, Jellinger K, Pearce RK, D'Olhaberriague L.

Brain. 1997 Jan;120 ( Pt 1):65-74.

PMID:
9055798
11.

Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.

Rivest J, Quinn N, Marsden CD.

Neurology. 1990 Oct;40(10):1571-8. Review.

PMID:
2215950
12.

A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy.

Josephs KA, Ishizawa T, Tsuboi Y, Cookson N, Dickson DW.

Arch Neurol. 2002 Oct;59(10):1597-601.

PMID:
12374498
13.

Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.

Wenning GK, Colosimo C.

Rev Neurol (Paris). 2010 Oct;166(10):829-33. doi: 10.1016/j.neurol.2010.07.004. Epub 2010 Sep 1. Review.

PMID:
20813385
14.

Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).

Tolosa E, Valldeoriola F, Marti MJ.

J Neural Transm Suppl. 1994;42:15-31. Review.

PMID:
7964684
15.

A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.

Halliday GM, Macdonald V, Henderson JM.

Brain. 2005 Oct;128(Pt 10):2272-80. Epub 2005 Jul 13.

PMID:
16014651
16.

[An assessment of dysphagia using videofluorography in Parkinson's disease and progressive supranuclear palsy].

Ichihara N, Ichihara SI, Fujii S, Touge T, Nishioka M.

Rinsho Shinkeigaku. 2000 Nov;40(11):1076-82. Japanese.

PMID:
11332186
17.

Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study.

Linder J, Stenlund H, Forsgren L.

Mov Disord. 2010 Feb 15;25(3):341-8. doi: 10.1002/mds.22987.

PMID:
20108376
18.

Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?

Lannuzel A, Höglinger GU, Verhaeghe S, Gire L, Belson S, Escobar-Khondiker M, Poullain P, Oertel WH, Hirsch EC, Dubois B, Ruberg M.

Brain. 2007 Mar;130(Pt 3):816-27. Epub 2007 Feb 15.

PMID:
17303592
19.

Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.

Tsuboi Y, Josephs KA, Boeve BF, Litvan I, Caselli RJ, Caviness JN, Uitti RJ, Bott AD, Dickson DW.

Mov Disord. 2005 Aug;20(8):982-8.

PMID:
15834857
20.

Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.

Rizzo G, Martinelli P, Manners D, Scaglione C, Tonon C, Cortelli P, Malucelli E, Capellari S, Testa C, Parchi P, Montagna P, Barbiroli B, Lodi R.

Brain. 2008 Oct;131(Pt 10):2690-700. doi: 10.1093/brain/awn195. Epub 2008 Sep 26.

PMID:
18819991

Supplemental Content

Support Center